[Pr-1]Antiglycolipid antibodies in autoimmune neuropathies; past, present and future
Susumu Kusunoki(Department of Neurology, Kindai University Faculty of Medicine)
60th Annual Meeting of the Japanese Society of Neurology
May 22 - May 25, 2019Osaka International Convention Center Corp Rihga Royal Hotel Osaka
You can search for presentations in this event.
Search
60th Annual Meeting of the Japanese Society of Neurology
May 22 - May 25, 2019Osaka International Convention Center Corp Rihga Royal Hotel Osaka
You can search for presentations in this event.
SearchSearch Results(2,075)
[PL-1]The depth and breadth of antibody-mediated neurological diseases
Angela Vincent(University of Oxford; University of London, UK)
[SPL-1]THE EVOLVING SPECTRUM OF ACUTE TRANSVERSE MYELITIS
Brian G. Weinshenker(Mayo Clinic Rochester, USA)
[SL-01-1]Frontier of genome analysis in clinical neurology
Shoji Tsuji1,2(1.Department of Molecular Neurology, The University of Tokyo, 2.Institute of Medical Genomics, International University of Health and Welfare)
[SL-02-1]Investigation of Human Neurological Diseases Using iPSCs-Technologies and GM Non-Human Primate
Hideyuki Okano(Keio University School of Medicine)
[SL-03-1]History and future prospective of Kindai-Tuna
Yoshifumi Sawada(Aquaculture Research Institute, Kindai University)
[SP-1]Augusta Klumpke; the first woman neurologist
Makoto Iwata(Medical Clinic Kakinokizaka)
[SS-01-1]An 83-year-old female brain donor with gait disturbance and fall
Mari Shibukawa1, Renpei Sengoku1,2, Tomoyasu Matsubara2, Kenji Ishii3, Aya Tokumaru4, Kazutomi Kanemaru1, Shigeo Murayama1,2(1.Department of Neurology, Tokyo Metropolitan Geriatric Hospital, 2.The Brain Bank for Aging Resaerch, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 3.Research on Neuroimaging, Tokyo Metropolitan Institute of Gerontology, 4.Department of Diagnostic Radiology, Tokyo Metropolitan Geriatric Hospital)
[SS-01-2]Co-morbidity of Parkinson's disease and amyotrophic lateral sclerosis
Yuishin Izumi1, Shigeo Murayama2(1.Department of Neurology, Tokushima University Hospital, 2.Department of Neuropathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology)
[SS-02-1]Intractable disease health care provider system for neurological diseases
Takafumi Miyachi(National Hospital Organization, Yanai Medical Center)
[SS-02-2]The questionnaire survey on clinical multidisciplinary team for intractable diseases
Tatsuya Abe(Department of Neurology, Center for Neuromuscular and Intractable diseases, National Hakone Hospital)
[SS-02-3]How to balance work with neurological disease treatment
Hina Uetake(National Hospital Organization Matsumoto Medical Center)
[SS-02-4]The picture of rehabilitation for intractable diseases
Takayo Chuma(Department of Rehabilitation Medicine, Shiga General Hospital)
[SS-02-5]Current situation and challenges of measures against intractable/rare diseases
Akiko Tanaka(Ministry of Health, Labour and Welfare, Japan)
[SS-03-1]The Role of Teleneurology between Indonesia and Japan in Improving Neuroimmunology Knowledge
Riwanti Estiasari1, Darma Imran1,2, Kartika Maharani1,2, David Pangeran1, Nopa Krismanto4, Aria Kekalih3(1.Department of Neurology, Faculty of Medicine Universitas Indonesia, Indonesia, 2.Cipto Mangunkusumo Hospital Jakarta, Indonesia, 3.Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Indonesia, 4.IT Division, Faculty of Medicine Universitas Indonesia, Indonesia)
[SS-03-2]Monthly teleconference on neuroimmunological diseases with Indonesia institutes: from Japanese side
Noriko Isobe(Department of Neurological Therapeutics, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan)
[SS-03-3]International education program from my experience: JSN, IFCN, MDS
Yoshikazu Ugawa(Department of Neuro-Regeneration, Fukushima Medical University, Japan)
[SS-03-4]International education on muscular diseases
Ichizo Nishino(Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan)
[SS-03-5]How to join English teleconference on neurologicial diseases
Yasushi Kisanuki(Department of Neurology, The Ohio State University Wexner Medical Center, USA)
[SS-04-1]The Future Practice of Neurology: Coordinated, Team-Care Models to Improve Outcomes in Populations
Barbara G. Vickrey(Icahn School of Medicine at Mount Sinai, USA)
[SS-04-2]Emerging neurological infections
Justin C. McArthur1,2(1.Sheikh Khalifa Stroke Institute, Johns Hopkins University, USA, 2.Department of Neurology, Johns Hopkins University School of Medicine, USA)
[SS-04-3]Emerging genetic and cellular insights into HSP pathogenesis
Craig Blackstone(Neurogenetics Branch, NINDS, US National Institutes of Health, USA)
[SS-05-1]The attraction of basic research
Tatsushi Toda(Department of Neurology, Graduate School of Medicine, The University of Tokyo)
[SS-05-2]Welcome to basic sciences, a message from the President of the Japan Neuroscience Society
Tadashi Isa1,2,3(1.Graduate School of Medicine, Kyoto University, 2.Institute for the Advanced Study of Human Biology, Kyoto University, 3.Human Brain Science Center, Kyoto University)
[SS-05-3]Wonderful world created by the research in neurochemistry
Keiji Wada(National Institute of Neuroscience, National Center of Neurology and Psychiatry)
[SS-06-1]ICD-11 revision and the Japanese contribution
Kei Mori, Emiko Oikawa, Koki Abe, Kaori Nakayama(International Classification and Information Management Office to the Director-General for Statistics, Information Policy and Policy Evaluation, Ministry of Health, Labour and Welfare)
[SS-06-2]Neurology and Neurosurgery in ICD11
Raad Shakir(Imperial College London University, UK)
[SS-06-3]Reserach framework for Alzheimer's disease
Philip Scheltens(Amsterdam University Medical Centers, The Netherlands)
[SS-06-4]Prion disease is moved from atypical infections of central nervous system to neurological disease
Hidehiro Mizusawa1,2(1.National Center of Neurology and Psychiatry, Japan, 2.Tokyo Medical and Dental University, Japan)
[AW-1]Identification of novel molecules to modify the blood-brain barrier in neuroimmunological diseases (Scientific Research Category)
Fumitaka Shimizu(Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan)
[AW-2]Elucidation of genomic background of sporadic Parkinson's disease (Scientific Research Category)
Wataru Satake(Div Neurol/Mol Bra Sci)
[AW-3]Neurology of the Bladder and Bowel: a hidden but important area of neuroscience (Clinical Research Category)
Ryuji Sakakibara(Neurology, Internal Medicine, Sakura Medical Center, Toho University)
[NFS-01-1]Molecular pathogenesis of benign adult familial myoclonic epilepsy (BAFME)
Hiroyuki Ishiura(Department of Neurology, The University of Tokyo, Japan)
[NFS-01-2]Pathogenesis of SCA31
Kinya Ishikawa(The Center for Personalized Medicine for Healthy Aging, Tokyo Medical and Dental University, Japan)
[NFS-01-3]Mechanistic and Therapeutic Insights into Repeat Expansions Disorders
Leonard Petrucelli(Mayo Clinic, USA)
[NFS-02-1]Gene therapy with therapeutic oligonucleotide
Tetsuya Nagata(Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan)
[NFS-02-2]Block of neuraxial degeneration by silencing an ALS-causing mutant gene with subpial AAV9 delivery
Martin Marsala1, Don W. Cleveland2, Brian K. Kaspar3, Mariana Bravo-hernandez1, Takahiro Tadokoro1(1.University of California, San Diego, USA, 2.Ludwig Institute for Cancer Research and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, USA;, 3.Avexis Inc., Chicago, USA)
[NFS-02-3]Gene therapy for Parkinson's disease
Shin-ichi Muramatsu1,2,3(1.Division of Neurology, Department of Medicine, Jichi Medical University, Japan, 2.Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo, Japan, 3.Department of Neurology, Osaka University Graduate School of Medicine, Japan)
[NFS-02-4]Gene therapy against SCA1 based on the molecular pathomechanism
Hitoshi Okazawa1,2(1.Department of Neuropathology, Medical Research Institute, Tokyo Medical and Dental University, Japan, 2.Center for Brain Integration Research, Tokyo Medical and Dental University, Japan)
[NFS-02-5]iPS cell-based therapy for Parkinson's disease
Jun Takahashi(Center for iPS Cell Research and Application, Kyoto University, Japan)
[G-01-1]Sleep Disorders and Epilepsy
Yasunori Oka(Ehime University Hospital)
[G-01-2]Post-stroke epilepsy
Tomotaka Tanaka1,2(1.National Cerebral and Cardiovascular Center, 2.National University of Singapore)
[G-01-3]Dementia and epilepsy
Takashi Matsudaira(National Epilepsy Center, NHO Shizuoka Institute of Epilepsy and Neurological Disorders)
[G-01-4]Autoimmune epilepsy
Riki Matsumoto(Kobe University Graduate School of Medicine)
[G-02-1]New Clinical Diagnostic Criteria for Parkinson's Disease
Satoshi Orimo(Department of Neurology, Kanto Central Hospital)
[G-02-2]Treatment of early Parkinson Disease
Atsushi Takeda(Department of Neurology, Sendai-Nishitaga Hospital)
[G-02-3]Treatment of Advanced Parkinson's disease
Yasushi Shimo, Nobutaka Hattori(Department of Neurology, Juntendo University School of Medicine)
[HT-01-1]Introduction: what is the true culprit of neurodegeneration in PD; alpha-synuclein and beyond?
Takahiko Tokuda(Department of Molecular Pathobiology of Brain Diseases, Kyoto Prefectural University of Medicine, Japan)
[HT-01-2]Molecular and cellular basis of neurotoxicity caused by alpha-synuclein
Naoto Sugeno(Department of Neurology, Tohoku University, Japan)
[HT-01-3]Hyperbranching axon as a structural template to explain focal and multifocal Lewy body disorders
Toshiki Uchihara1,2(1.Neurology with Neuromorphomics Laboratory, Nitobe Memorial Nakano General Hospital, Japan, 2.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan)
2,075 results ( 1 - 50 )
- 1
- ...